• Profile
Close

Week in review: Chameleon contacts, OTC olopatadine, blinding blue

American Academy of Ophthalmology News Feb 25, 2020

A weekly roundup of ophthalmic news from around the web.
 
Novartis’ new anti-VEGF agent brolucizumab is now approved for wet AMD in Europe, 4 months after the drug was cleared by the FDA. The European Commission’s decision is applicable to all 27 European Union member states as well as the United Kingdom, Iceland, Norway and Liechtenstein. Novartis
 
Chinese scientists say their new smart contact lens could be the ideal tool for diagnosing xerophthalmia and high IOP. Crafted from a biocompatible hydrogel, the lenses are structurally—but not chemically—pigmented and can alter its color in response to changes in moisture and pressure. They report that the lens transforms from red to blue when placed in xerophthalmia-simulating conditions, but remains unchanged in normal eye environments. The team hope this novel device will inspire a new generation of wearable, colorimetric sensing tools that can deliver real-time monitoring of signs and disease. (Image by DU Xuemin) Shenzhen Institute of Advanced Technology of the Chinese Academy of Sciences
 
Alcon’s olopatadine eye drops for allergy itch relief are now cleared for nonprescription use, according to the company’s press release. The FDA approved the adjustment through a process called a prescription-to-over the counter switch. Alcon hopes the move will make the treatment—indicated for temporary relief of itchy eyes due to pollen, ragweed, grass, animal hair and dander—more accessible to the masses. The Pataday once- and twice-daily treatments will be available in the United States beginning March 2, just in time for allergy season. Alcon, FDA
 
Jan Sears, a California Highway Patrol pilot, was temporarily blinded by a blue laser while on duty. "So it’s pitch black and we’re flying and all of the sudden it’s like the sun just came out," he told the local news, explaining that these types of attacks have been on the rise. Luckily, Sears managed to maintain control of his plane but is still experiencing residual effects from the attack in his left eye. His assailant, who was illegally using a high powered laser, was arrested and faces possible jail time. SF gate, CBS 13 Sacramento
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay